Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
5.71
-0.08 (-1.38%)
At close: Sep 17, 2025, 4:00 PM EDT
5.71
0.00 (0.00%)
Pre-market: Sep 18, 2025, 5:26 AM EDT
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $445.70 million as of September 18, 2025. Its market cap has decreased by -35.85% in one year.
Market Cap
445.70M
Enterprise Value
118.69M
1-Year Change
-35.85%
Ranking
Category
Stock Price
$5.71
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has decreased from $467.51M to $445.70M, a decrease of -4.67%. That is a compound annual growth rate of -0.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 445.70M | -52.17% |
| Dec 31, 2024 | 931.93M | 87.18% |
| Dec 29, 2023 | 497.87M | -67.63% |
| Dec 30, 2022 | 1.54B | 21.04% |
| Dec 31, 2021 | 1.27B | -27.53% |
| Dec 31, 2020 | 1.75B | 245.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 685.87B |
| Johnson & Johnson | 426.76B |
| AbbVie | 390.30B |
| UnitedHealth Group | 307.93B |
| Novo Nordisk | 260.64B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 232.94B |